The rise of Viagra initially sparked a period of growth for pharma, nevertheless here recent developments present a complicated scenario for those considering a stake. Off-patent versions are reducing revenue, and ongoing legal battles add additional risk to the landscape. While specific companies might still see gains from adjacent services, the o